These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21199899)

  • 1. A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development.
    Bemark M; Bergqvist P; Stensson A; Holmberg A; Mattsson J; Lycke NY
    J Immunol; 2011 Feb; 186(3):1399-410. PubMed ID: 21199899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells contribute to the mucosal adjuvant effect of CTA1-DD after IgG-complex formation.
    Fang Y; Larsson L; Mattsson J; Lycke N; Xiang Z
    J Immunol; 2010 Sep; 185(5):2935-41. PubMed ID: 20675596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects.
    Agren L; Sverremark E; Ekman L; Schön K; Löwenadler B; Fernandez C; Lycke N
    J Immunol; 2000 Jun; 164(12):6276-86. PubMed ID: 10843681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.
    Mattsson J; Yrlid U; Stensson A; Schön K; Karlsson MC; Ravetch JV; Lycke NY
    J Immunol; 2011 Oct; 187(7):3641-52. PubMed ID: 21880985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-21 receptor is critical for the development of memory B cell responses.
    Rankin AL; MacLeod H; Keegan S; Andreyeva T; Lowe L; Bloom L; Collins M; Nickerson-Nutter C; Young D; Guay H
    J Immunol; 2011 Jan; 186(2):667-74. PubMed ID: 21169545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented antibody response with premature germinal center regression in CD40L transgenic mice.
    Kishi Y; Aiba Y; Higuchi T; Furukawa K; Tokuhisa T; Takemori T; Tsubata T
    J Immunol; 2010 Jul; 185(1):211-9. PubMed ID: 20505144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.
    Agren LC; Ekman L; Löwenadler B; Lycke NY
    J Immunol; 1997 Apr; 158(8):3936-46. PubMed ID: 9103464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired affinity maturation in Cr2-/- mice is rescued by adjuvants without improvement in germinal center development.
    Wu X; Jiang N; Fang YF; Xu C; Mao D; Singh J; Fu YX; Molina H
    J Immunol; 2000 Sep; 165(6):3119-27. PubMed ID: 10975825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.
    Agren LC; Ekman L; Löwenadler B; Nedrud JG; Lycke NY
    J Immunol; 1999 Feb; 162(4):2432-40. PubMed ID: 9973526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants.
    Mastelic B; Kamath AT; Fontannaz P; Tougne C; Rochat AF; Belnoue E; Combescure C; Auderset F; Lambert PH; Tacchini-Cottier F; Siegrist CA
    J Immunol; 2012 Dec; 189(12):5764-72. PubMed ID: 23162125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and maintenance of a B220- memory B cell compartment.
    Driver DJ; McHeyzer-Williams LJ; Cool M; Stetson DB; McHeyzer-Williams MG
    J Immunol; 2001 Aug; 167(3):1393-405. PubMed ID: 11466358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen.
    Mowat AM; Donachie AM; Jägewall S; Schön K; Löwenadler B; Dalsgaard K; Kaastrup P; Lycke N
    J Immunol; 2001 Sep; 167(6):3398-405. PubMed ID: 11544331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity IgM(+) memory B cells are generated through a germinal center-dependent pathway.
    Hara Y; Tashiro Y; Murakami A; Nishimura M; Shimizu T; Kubo M; Burrows PD; Azuma T
    Mol Immunol; 2015 Dec; 68(2 Pt C):617-27. PubMed ID: 26514429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity.
    Lycke N; Schön K
    Vaccine; 2001 Mar; 19(17-19):2542-8. PubMed ID: 11257390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antigen-specific B-cell memory directly ex vivo.
    McHeyzer-Williams LJ; McHeyzer-Williams MG
    Methods Mol Biol; 2004; 271():173-88. PubMed ID: 15146121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas.
    Bolduc A; Long E; Stapler D; Cascalho M; Tsubata T; Koni PA; Shimoda M
    J Immunol; 2010 Jul; 185(1):220-30. PubMed ID: 20505142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal Immunization Using CTA1-DD as a Mucosal Adjuvant for an Inactivated Influenza Vaccine.
    Fan XT; Wang YL; Su QD; Qiu F; Yi Y; Jia ZY; Wang DY; Qin K; Zou YN; Bi SL; Shen LP
    Biomed Environ Sci; 2019 Jul; 32(7):531-540. PubMed ID: 31331437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization.
    Fang Y; Zhang T; Lidell L; Xu X; Lycke N; Xiang Z
    Mucosal Immunol; 2013 Nov; 6(6):1168-78. PubMed ID: 23571505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens.
    Basu S; Ray A; Dittel BN
    PLoS One; 2013; 8(6):e67587. PubMed ID: 23826323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.